Clinical Study

The Associations of Serum Uric Acid with Obesity-Related Acanthosis nigricans and Related Metabolic Indices

Table 1

General anthropometric and metabolic characteristics of the study cohort divided by females and males.

ParametersFemale ()Male ()
OB ()AN ()OB ()AN ()

UA (μmol/L)344.2 ± 65.1407.8 ± 89.1<0.001430.6 ± 82.4496.3 ± 112.5<0.001
Age (yr)31 (12)26 (12)<0.00130 (10)24 (14)<0.001
Weight (kg)81.77 ± 11.4395.15 ± 15.23<0.001106.52 ± 14.79114.42 ± 20.040.002
BMI (kg/m2)30.99 ± 3.5235.10 ± 5.04<0.00134.29 ± 3.9636.79 ± 5.220.002
Waist circumference (cm)99.46 ± 9.49109.99 ± 12.62<0.001112.51 ± 10.46117.03 ± 11.630.011
Waist/hip ratio0.916 ± 0.0690.960 ± 0.062<0.0010.987 ± 0.0590.998 ± 0.0440.137
Percentage of body fat (%)36.98 ± 3.4138.68 ± 4.380.00231.88 ± 5.2132.72 ± 4.990.940
SBP (mmHg)128 ± 17135 ± 150.006133 ± 14140 ± 140.001
DBP (mmHg)83 ± 1087 ± 110.01483 ± 1185 ± 110.305
Cr (μmol/L)56.88 ± 7.3656.82 ± 8.880.96474.95 ± 13.7174.28 ± 13.290.760
ALT (U/L)32.72 ± 26.9756.96 ± 41.55<0.00161.73 ± 56.2185.08 ± 58.03<0.001
AST (U/L)25.19 ± 14.0634.77 ± 20.29<0.00133.92 ± 27.9643.84 ± 24.35<0.001
TC (mmol/L)5.02 ± 1.124.86 ± 0.930.4734.93 ± 0.954.97 ± 1.000.774
TG (mmol/L)1.64 ± 0.992.03 ± 2.490.3992.02 ± 1.171.79 ± 0.830.207
HDL (mmol/L)1.16 ± 0.261.13 ± 0.490.0561.04 ± 0.190.97 ± 0.190.015
LDL (mmol/L)3.08 ± 1.012.97 ± 0.860.6503.09 ± 0.833.22 ± 0.850.307
BG0 (mmol/L)5.41 ± 1.095.77 ± 1.700.0795.81 ± 2.195.38 ± 1.100.471
INS0 (mU/L)23.91 ± 21.4034.12 ± 17.91<0.00125.64 ± 18.4839.66 ± 31.74<0.001
CP0 (ng/mL)3.37 ± 1.284.42 ± 1.30<0.0013.68 ± 1.434.75 ± 1.82<0.001
HOMA-IRa1.54 ± 0.642.01 ± 0.61<0.0011.67 ± 0.702.04 ± 0.65<0.001

Data are expressed as mean ± SD or median (interquartile range); versus OB, ; ; ; athe data was ln-transformed to normality before analysis. AN: obese group with Acanthosis nigricans; OB: simple obese group; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; UA: uric acid; Cr: serum creatinine; ALT: alanine transaminase; AST: aspertate aminotransferase; TC: total cholesterol; TG: triglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein; BG0: 0 min glucose; INS0: 0 min insulin; CP0: 0 min C peptide; HOMA-IR: homeostasis assessment model of insulin resistance.